- No.198 Aryl Hydrocarbon Receptor in Health and Disease
- No.197 The Role of Aryl Hydrocarbon Receptor in Skin Homeostasis: Implications for Therapeutic Strategies in Skin Disorders
- No.196 The Aryl Hydrocarbon Receptor (AhR): Peacekeeper of the Skin
- No.195 The aryl hydrocarbon receptor: structure, signaling, physiology and pathology
- No.194 The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
- No.193 Activation of the aryl hydrocarbon receptor with structurally diverse ligands suppresses class switch to immunoglobulin A
- No.192 Benefits of equilibrium between microbiota and host-derived ligands of the aryl hydrocarbon receptor after stroke in aged male mice
- No.191 Physiological activation of Aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD1 therapy
- No.190 Computational discovery of novel aryl hydrocarbon receptor modulators for psoriasis therapy
- No.189 Gut microbiota shapes cancer immunotherapy responses
- No.188 Microbiota-indole-3-propionic acid-heart axis mediates the protection of leflunomide against αPD1-induced cardiotoxicity in mice
- No.187 Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT comple
- No.186 Aryl hydrocarbon receptor confers protection against macrophage pyroptosis and intestinal inflammation through regulating polyamine biosynthesis
- No.185 The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis
- No.184 Activation of the aryl hydrocarbon receptor improves allergen-specific immunotherapy of murine allergic airway inflammation: a novel adjuvant option?
- No.183 Mechanisms underlying aryl hydrocarbon receptor-driven divergent macrophage function
- No.182 Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases
- No.181 Role of aryl hydrocarbon receptors in infection and inflammation
- No.180 Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease
- No.179 The Aryl Hydrocarbon Receptor Regulates Epidermal Differentiation through Transient Activation of TFAP2A
- No.178 The modern human aryl hydrocarbon receptor is more active when ancestralized by genome editing
- No.177 The aryl hydrocarbon receptor shapes monocyte transcriptional responses to interleukin-4 by prolonging STAT6 binding to promoters
- No.176 Identifying novel aryl hydrocarbon receptor (AhR) modulators from clinically approved drugs: In silico screening and In vitro validation
- No.175 Itching for innovation: the role of aryl hydrocarbon receptor agonists as a future therapy for atopic dermatitis
- No.174 GDU-952, a novel AhR agonist ameliorates skin barrier abnormalities and immune dysfunction in DNFB-induced atopic dermatitis in mice
- No.173 Characterizing the impact of simvastatin co-treatment of cell specific TCDD-induced gene expression and systemic toxicity
- No.172 Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance
- No.171 Nuclear localization of STING1 competes with canonical signaling to activate AHR for commensal and intestinal homeostasis
- No.170 AhR and CYP1B1 Control Oxygen Effects on Bone Marrow Progenitor Cells: The Enrichment of Multiple Olfactory Receptors as Potential Microbiome Sensors
- No.169 Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy